Trial intelligence / Profile preview

Preoperative Gabapentin Versus Bisoprolol in Endoscopic Sinus Surgery

NCT03850093Phase 4Completed

Sponsor
Zagazig University
Start
Aug 2015
Primary completion
Oct 2016
Modality
Small Molecules
01

Overview

Phase 4, randomised, double-blind trial of gabapentin in chronic rhinosinusitis (CRS) (3 arms), sponsored by Zagazig University. Primary endpoints: Changes in Surgical Field Visibility and Intraoperative Blood Loss. Started Aug 2015; status: completed.

02

Drugs

gabapentin
03

Conditions

chronic rhinosinusitis (CRS)

Beyond the preview

Go deeper on NCT03850093.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03850093.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call